ARBs block AT1 receptors (the effects mediated by AT1 receptors of angiotensin II include vasoconstriction, endothelial dysfunction, neurodegeneration, and other potentially harmful effects) and stimulate AT2 receptors (the effects of AT2 receptors counteract the effects of AT1 receptors). Here, AGTR2 is linked to endothelial dysfunction.